Pressure Bio's Q1 Revenues Rise on Instrument Sales | GenomeWeb

NEW YORK (GenomeWeb News) – Pressure BioSciences today reported that its first-quarter revenues increased to $306,762 from $132,376 year over year.

The firm said that sales of its Pressure Cycling Technology products and services were $222,142 versus $81,473 in the comparable quarter of 2008. Pressure Bio said the sales growth was driven by the installation of 10 Barocycler instruments during the quarter, compared to seven such sales in Q1 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.